Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Brain Neoplasms 23Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 11Neoplasm Metastasis 8Melanoma 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Carcinoma, Renal Cell 4Small Cell Lung Carcinoma 3Meningioma 3Urinary Bladder Neoplasms 2Sarcoma 2Prostate Adenocarcinoma 2Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Gastrointestinal Neoplasms 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Stage II Prostate Adenocarcinoma AJCC v7 1

Interventions

Irinotecan 2Cyclophosphamide 2tocilizumab 1regorafenib 1poly ICLC 1pembrolizumab 1palbociclib 1liposomal doxorubicin 1fludarabine 1flt3 ligand protein 1aldesleukin 1Topotecan 1Temozolomide 1Taxes 1Radiotherapy 1Radiosurgery 1Radiation 1Paclitaxel 1Observation 1Nivolumab 1Lomustine 1Ipilimumab 1Gemcitabine 1Fitness Trackers 1Doxorubicin 1Carboplatin 1CTLA-4 Antigen 1Biopsy, Needle 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Bone Neoplasms × Radiosurgery × Clear all
NCT02880319 2025-09-09

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
150 enrolled 12 charts
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡